Dr Reddys recalls 2,980 bottles of Atorvastatin Calcium tablets in US over quality issues
New Delhi: Drug major Dr Reddy's Laboratories is recalling 2,980 bottles of Atorvastatin Calcium tablets in the US due to quality issues.
Atorvastatin is indicated to lower cholesterol in the blood for adults and children over ten years of age.
The drug is also prescribed to lower the risk of heart attack and stroke in patients with cardiovascular diseases, diabetes, and other risk factors such as eye problems, kidney diseases, or high blood pressure.
As per the US Food and Drug Administration's latest Enforcement report, the Hyderabad-based drug major is voluntarily recalling the affected lots of the drug in 10 mg strength due to "failed impurities degradation specifications".
The 500-count 2,980 bottles have been produced at Dr Reddy's Bachupally (Telangana) plant and later shipped to its US arm which is now in the process of recalling the lot.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.